ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$16.53 USD
+0.11 (0.67%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.54 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 20 |
Average Target Price | $24.89 |
LT Growth Rate | 57.70% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 253 |
Current Quarter EPS Est: | 0.11 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 13 | 13 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 5 | 5 | 5 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.80 | 1.80 | 1.80 | 1.70 | 1.70 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | UBS | Ashwani Verma | Strong Buy | Strong Buy |
8/7/2024 | Mizuho SecuritiesUSA | Uy D Ear | Hold | Hold |
8/7/2024 | Needham & Company | Ami Fadia | Moderate Buy | Moderate Buy |
8/7/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
7/24/2024 | Cantor Fitzgerald & Co | Charles C Duncan | Strong Buy | Strong Buy |
6/30/2024 | Goldman Sachs | Salveen Richter | Strong Sell | Strong Sell |
6/27/2024 | BMO Capital Markets | Evan Seigerman | Not Available | Strong Buy |
6/25/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/8/2024 | SVB Securities | Marc Goodman | Strong Buy | Strong Buy |
5/8/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Strong Buy |
3/12/2024 | Canaccord Genuity | Sumant Kulkarni | Strong Buy | Strong Buy |
3/12/2024 | Robert W. Baird & Co. | Joel L Beatty | Strong Buy | Strong Buy |
3/12/2024 | JMP Securities | Jason N Butler | Strong Buy | Strong Buy |
2/27/2024 | Guggenheim Securities | Yatin Suneja | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.